This inventor holds 2 USPTO granted patents. Top assignees: 3-Dimensional Pharmaceuticals, Inc., Janssen Pharmaceutica Nv. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2010
Title: Inventor Spotlight: Jonathan Rudolph
Introduction
Jonathan Rudolph is an accomplished inventor based in Doylestown, PA, known for his significant contributions to the field of medicine through innovative pharmaceutical compounds. With two patents to his name, his work primarily focuses on developing treatments for autoimmune diseases, various cancers, and pain management.
Latest Patents
Jonathan's latest patents showcase his expertise in creating compounds that serve as inhibitors of c-fms kinase, targeting critical pathways in disease progression. His first patent involves a class of arylamide compounds that effectively inhibit protein tyrosine kinases, especially c-fms kinase. This invention holds promise for treating autoimmune diseases and inflammatory conditions, as well as various cancers such as ovarian, uterine, breast, colon, and stomach cancer. Additionally, it addresses pain management arising from tumor metastasis and osteoarthritis, alongside other conditions like osteoporosis and Paget's disease.
His second patent entails thiophene amidines and their compositions, outlining methods for managing disorders mediated by the classical pathway of the complement cascade. This innovative approach targets acute and chronic conditions, utilizing compounds to improve health outcomes for patients in need of effective treatments.
Career Highlights
Throughout his career, Jonathan has made notable strides in the pharmaceutical industry. He has worked with esteemed companies such as 3-Dimensional Pharmaceuticals, Inc. and Janssen Pharmaceutica N.V., where he honed his skills in drug development and innovative research. His contributions have significantly enhanced the landscape of therapeutic options available to patients.
Collaborations
Jonathan has also collaborated with talented professionals in his field, including colleagues Shelley K. Ballentine and Sanath K. Meegalla. These partnerships have further propelled his research endeavors and contributed to the success of his inventions.
Conclusion
In summary, Jonathan Rudolph stands out as a dedicated inventor whose innovative work is making a tangible impact in the realm of medicine. With his focus on developing targeted treatments for complex diseases, he continues to pave the way for future advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile